Pixantrone (BBR 2778) in Patients With Refractory Acute Myelogenous Leukemia (AML)

NCT00106600 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Myelogenous Leukemia

Interventions

DRUG: Pixantrone IV infusion

Sponsor

CTI BioPharma